Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Mixed Anhydride Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for Nirmatrelvir intermediates using mixed anhydrides reduces racemization and boosts yield for reliable API manufacturing.
Patent CN114057751B reveals a greener route for Linagliptin intermediates, eliminating genotoxic reagents and boosting yield for reliable API supply chains.
Novel activation-condensation route for Sitagliptin intermediates. High yield, industrial scalability, cost-effective alternative to HOBt/EDC methods.
Novel one-pot synthesis of Cefcapene diisopropylamine salt. High purity, scalable process avoiding inorganic alkali. Cost-effective manufacturing solution.
Patent CN101781311A reveals a high-yield one-pot synthesis for stable platelet aggregation inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102617506B reveals a novel Cefdinir synthesis route using methylsulfonyl chloride, offering high purity and cost reduction in API manufacturing for global supply chains.
Patent CN101519428B details a low-cost, high-purity synthesis of L-alanyl-L-glutamine using mixed anhydride activation, offering significant supply chain advantages.
Patent CN109640658A details a scalable synthesis for fungicidal picolinamide intermediates, offering enhanced purity and cost-effective manufacturing solutions.